Clinical trial
Pediatric ADVAIR DISKUS Versus Oral Montelukast Chewable Tablets
NCT00328718 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00328718 |
|---|---|
| Title | Pediatric ADVAIR DISKUS Versus Oral Montelukast Chewable Tablets |
| Official title | Randomised, Double-blind, Double-dummy, Parallel-group, Comparative Study of Salmeterol/FP 50/100mcg bd Inhalation Powder Via Diskus With Oral Montelukast (5mg QD) Chewable Tablets in Children 6-14 Years |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | montelukast (5mg QD), Salmeterol/Fluticasone propionate Inhalation Powder (50/100mcg BID) |
| Enrollment | 526 |
| Start date | Oct 1, 2005 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | May 22, 2006 |
| Last update posted | Jan 20, 2017 |
| Countries | Argentina, Colombia, Costa Rica, Mexico, Peru, Turkey (Türkiye), Venezuela |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: